Organization name

Ansell Healthcare Europe NV

SRN

BE-MF-000000691

Manufacturer status

Active

3 warnings recorded — scroll inside the panel to see all entries.

• Consult instructions for use
• Do not re-use
• Caution

  This product contains natural rubber latex which can cause allergic reactions, including anaphylactic responses.

Primary placement in Belgium; available across 32 countries total.

Trade name

MICRO-TOUCH Ultra II

UDI-DI code

Primary DI

The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.

25414566320622

Basic UDI-DI

Basic UDI-DI

The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.

5414566MTS11U11YF

Reference / catalog number

553692 Size S

Issuing entity

UDI issuing entities

Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.

GS1

Risk category

MDR risk classes

MDR risk classes rank medical devices from lowest risk (Class I) to highest (Class III), which determines how much regulatory scrutiny they face.

Class I

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

100

Additional product description

—

Additional information URL

https://www.ansell.com/eu/en/products/micro-touch-ultra-ii

Clinical sizes

No clinical sizes registered for this device.

1 packaging level registered — each level carries its own UDI-DI.

• 25414566320622× 100 unitsBase unit
  • 35414566320629× 10 units

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

European Medical Device Nomenclature — the EU product classification assigned to this device.

• T010201LATEX EXAMINATION / TREATMENT GLOVES

• Class I medical devices in EUDAMED

No certificate specifically references this device's Basic UDI-DI.